The FDA announced that  it "approved a new warning on Allergan Inc's Botox and a similar product about the possibility of life-threatening breathing and swallowing problems."  In addition to "signing off on a boxed warning for Botox and Myobloc, made by Solstice Neurosciences Inc." the FDA said "it was changing the generic names for both products to avoid medication errors," even though the "brand names and product formulations are not changing."  Source: Dow Jones Newswires.